Tenaya Therapeutics Inc. (TNYA)
1.47
0.04 (2.80%)
At close: Jan 15, 2025, 9:30 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 8.69M | 8.71M | 4.03M | 2.48M | 1.99M |
| Gross Profit | -8.69M | -8.71M | -4.03M | -2.48M | -1.99M |
| Operating Income | -131.19M | -125.62M | -72.81M | -38.91M | -27.71M |
| Interest Income | 7.06M | 1.95M | 108.00K | 87.00K | 453.00K |
| Pretax Income | -124.08M | -123.67M | -72.72M | -38.40M | -26.23M |
| Net Income | -124.08M | -123.66M | -69.65M | -38.31M | -25.78M |
| Selling & General & Admin | 33.16M | 31.08M | 18.41M | 7.81M | 4.56M |
| Research & Development | 98.04M | 94.54M | 54.39M | 31.10M | 23.15M |
| Other Expenses | n/a | 2.00K | -23.00K | 430.00K | 1.03M |
| Operating Expenses | 131.19M | 125.62M | 72.81M | 38.91M | 27.71M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 131.19M | 125.62M | 72.81M | 38.91M | 27.71M |
| Income Tax | n/a | -1.96K | -3.07M | -87.00K | -453.00K |
| Shares Outstanding (Basic) | 73.79M | 44.82M | 41.29M | 41.12M | 41.12M |
| Shares Outstanding (Diluted) | 73.79M | 44.82M | 41.29M | 41.12M | 41.12M |
| EPS (Basic) | -1.68 | -2.76 | -1.69 | -0.93 | -0.63 |
| EPS (Diluted) | -1.68 | -2.76 | -1.69 | -0.93 | -0.63 |
| EBITDA | -122.51M | -114.95M | -68.70M | -36.43M | -25.72M |
| Depreciation & Amortization | 8.69M | 8.71M | 4.03M | 2.48M | 1.99M |